Robots vs cameras: which surgery wins for lung cancer?
NCT ID NCT06524427
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of minimally invasive surgery for early-stage non-small cell lung cancer: robot-assisted lobectomy (using the Da Vinci system) and video-assisted lobectomy. Over 1,100 participants will be randomly assigned to one of the two procedures. The main goal is to see if robot surgery is at least as good as video surgery in terms of 5-year survival without cancer returning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Robot-assisted lobectomy using Da Vinci surgical system
- What this could lead to
- If robot-assisted surgery proves better or equal to video-assisted surgery, it could become a preferred option for early-stage lung cancer, potentially improving long-term survival and recovery.
- What could go wrong
- This is a non-inferiority trial, meaning it aims to show robot surgery is not worse than video surgery, not necessarily better. Results may show no significant advantage, and the study is still recruiting, so outcomes are years away.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, 400014, China
-
Gansu Provincial Hospital
RECRUITINGLanzhou, Gansu, 730000, China
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510080, China
-
Guangxi Nanxishan Hospital
RECRUITINGGuilin, Guangxi, 541002, China
-
Jiangsu Cancer Institute & Hospital
RECRUITINGNanjing, Jiangsu, 210009, China
-
Jiangxi Provincial People's Hopital
RECRUITINGNanchang, Jiangxi, 330006, China
-
Liaoning Tumor Hospital & Institute
RECRUITINGShenyang, Liaoning, 110042, China
-
Qianfoshan Hospital
RECRUITINGJinan, Shandong, 250014, China
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250012, China
-
Shandong Provincial Hospital
RECRUITINGJinan, Shandong, 250022, China
-
Shenzhen People's Hospital
RECRUITINGShenzhen, Guangdong, 518020, China
-
Shenzhen Third People's Hospital
RECRUITINGShenzhen, Guangdong, 518112, China
-
Sichuan Cancer Hospital and Research Institute
RECRUITINGChengdu, Sichuan, 610041, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
Tang-Du Hospital
RECRUITINGXi'an, Shaanxi, 710038, China
-
The Affiliated Hospital of Qingdao University
RECRUITINGQingdao, Shandong, 266003, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, 450052, China
-
The General Hospital of Eastern Theater Command
RECRUITINGNanjing, Jiangsu, 210002, China
-
The Second Hospital of Lanzhou University
RECRUITINGLanzhou, Gansu, 730030, China
-
West China Hospital
RECRUITINGChengdu, Sichuan, 610041, China
-
Wuhan TongJi Hospital
RECRUITINGWuhan, Hubei, 430030, China
-
Wuhan Union Hospital
RECRUITINGWuhan, Hubei, 430022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?